Recent Finacing
Recent Raise
Inoviv develops multiplexed, fully quantitative targeted proteomics assays and hybrid mass‑spectrometry workflows—measuring 50+ validated biomarkers in GLP/GCP‑accredited labs—tailored for clinical trial monitoring and pharmaceutical proteomics.
